SOAT1 and neoplasm: Aberrant JAK/STAT signaling has been associated with chronic inflammation, tumor immune evasion, and epithelial–mesenchymal transition (EMT), contributing to more aggressive tumor behavior [1,17,18,19,20,21,22] and reduced treatment response in CRC [23,24,25,26,27].